For CYP26B1 negative tumours (n = 200) the mean survival was 143 months (95%CI = 127–158 months) while for CYP26B1 positive tumours (n = 322) the mean survival was 104 months (95%CI = 94–114 months). This evidence concerns the gene CYP26B1 and neoplasm.